StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.48+0.02 (+0.34%)

Close on Nov 17, 2026Market cap $920.46MP/E –Yield –

Savara r&d expenses

Research and development expenses are spending on new products and technology.

Savara's R&D Expenses for the twelve months ending Jun 30, 2026 was $86.84M, up 4.0% year over year. For fiscal 2025 it was $81.40M, up 4.3% from the year before. Over ten years it grew 34.1% a year on average. The highest annual figure on record is $81.40M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$81.40M+4.3%
FY2024Dec 31, 2024$78.03M+76.3%
FY2023Dec 31, 2023$44.26M+58.8%
FY2022Dec 31, 2022$27.88M-3.8%
FY2021Dec 31, 2021$28.99M-17.3%
FY2020Dec 31, 2020$35.04M-9.7%
FY2019Dec 31, 2019$38.78M+4.3%
FY2018Dec 31, 2018$37.17M+100.8%
FY2017Dec 31, 2017$18.51M+126.3%
FY2016Dec 31, 2016$8.18M+89.4%
FY2015Dec 31, 2015$4.32M-77.8%
FY2014Dec 31, 2014$19.44M+50.6%
FY2013Dec 31, 2013$12.90M+59.5%
FY2012Dec 31, 2012$8.09M+40.5%
FY2011Dec 31, 2011$5.76M+56.1%
FY2010Dec 31, 2010$3.69M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$21.95M+5.8%
Q1 FY2026Mar 31, 2026$23.40M+22.1%
Q4 FY2025Dec 31, 2025$20.90M-10.3%
Q3 FY2025Sep 30, 2025$20.59M+1.4%
Q2 FY2025Jun 30, 2025$20.75M+17.8%
Q1 FY2025Mar 31, 2025$19.16M+14.0%
Q4 FY2024Dec 31, 2024$23.29M+82.8%
Q3 FY2024Sep 30, 2024$20.31M+46.5%
Q2 FY2024Jun 30, 2024$17.62M+97.7%
Q1 FY2024Mar 31, 2024$16.81M+92.3%
Q4 FY2023Dec 31, 2023$12.75M+67.1%
Q3 FY2023Sep 30, 2023$13.87M+70.1%
Q2 FY2023Jun 30, 2023$8.91M+38.8%
Q1 FY2023Mar 31, 2023$8.74M+53.7%
Q4 FY2022Dec 31, 2022$7.63M+0.1%
Q3 FY2022Sep 30, 2022$8.15M+24.8%
Q2 FY2022Jun 30, 2022$6.42M-11.5%
Q1 FY2022Mar 31, 2022$5.68M-25.1%
Q4 FY2021Dec 31, 2021$7.62M-25.0%
Q3 FY2021Sep 30, 2021$6.53M+16.6%
Q2 FY2021Jun 30, 2021$7.25M+19.3%
Q1 FY2021Mar 31, 2021$7.59M-42.5%
Q4 FY2020Dec 31, 2020$10.16M+16.4%
Q3 FY2020Sep 30, 2020$5.60M-41.5%
Q2 FY2020Jun 30, 2020$6.08M-41.9%
Q1 FY2020Mar 31, 2020$13.20M+31.7%
Q4 FY2019Dec 31, 2019$8.72M-11.5%
Q3 FY2019Sep 30, 2019$9.58M+0.7%
Q2 FY2019Jun 30, 2019$10.46M+12.9%
Q1 FY2019Mar 31, 2019$10.02M+17.3%
Q4 FY2018Dec 31, 2018$9.86M+53.2%
Q3 FY2018Sep 30, 2018$9.51M+91.5%
Q2 FY2018Jun 30, 2018$9.27M+122.6%
Q1 FY2018Mar 31, 2018$8.54M+189.7%
Q4 FY2017Dec 31, 2017$6.44M+84.5%
Q3 FY2017Sep 30, 2017$4.97M+131.8%
Q2 FY2017Jun 30, 2017$4.16M–
Q1 FY2017Mar 31, 2017$2.95M–
Q4 FY2016Dec 31, 2016$3.49M–
Q3 FY2016Sep 30, 2016$2.14M–

More Savara figures

See a number that looks wrong?